Are you sure Bedger ? at least IMHO OPT discussion at HC is well balanced and high IQ in the most part , infact I would say most discussion is pretty positive.
OPT from my perspective offers one of the best risk reward cases I have evaluated.
Ann: Opthea to Present at Clinical Trials at the Summit Meeting, page-3
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
59.8¢ |
Change
0.003(0.42%) |
Mkt cap ! $735.5M | |||
| Open | High | Low | Value | Volume |
| 59.0¢ | 60.3¢ | 58.5¢ | $316.3K | 529.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 30350 | 59.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 60.0¢ | 33778 | 23 |
View Market Depth
| Last trade - 11.52am 12/09/2024 (20 minute delay) ? |
| OPT (ASX) Chart |